Total Payments
$7,970
2024 Payments
$1,342
Companies
44
Transactions
405
Medicare Patients
12,109
Medicare Billing
$1.7M
Payment Breakdown by Category
Food & Beverage$7,946 (99.7%)
Education$24.44 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,946 | 402 | 99.7% |
| Education | $24.44 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,539 | 85 | $0 (2024) |
| ABBVIE INC. | $878.14 | 41 | $0 (2024) |
| Amgen Inc. | $844.63 | 36 | $0 (2024) |
| PFIZER INC. | $485.75 | 30 | $0 (2024) |
| GlaxoSmithKline, LLC. | $434.13 | 24 | $0 (2024) |
| Gilead Sciences, Inc. | $376.60 | 15 | $0 (2022) |
| Lilly USA, LLC | $318.12 | 13 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $298.17 | 6 | $0 (2024) |
| Allergan, Inc. | $251.34 | 19 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $236.15 | 13 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,342 | 67 | Novo Nordisk Inc ($319.66) |
| 2023 | $1,539 | 61 | AbbVie Inc. ($255.02) |
| 2022 | $966.23 | 49 | ABBVIE INC. ($196.95) |
| 2021 | $913.09 | 42 | Novo Nordisk Inc ($291.35) |
| 2020 | $935.76 | 63 | Amgen Inc. ($163.30) |
| 2019 | $608.24 | 30 | Novo Nordisk Inc ($247.12) |
| 2018 | $935.03 | 48 | Takeda Pharmaceuticals U.S.A., Inc. ($195.05) |
| 2017 | $731.10 | 45 | Novo Nordisk Inc ($150.54) |
All Payment Transactions
405 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: HIV | ||||||
| 12/19/2024 | Philips North America LLC | (5050) Ext Holter (Device) | Food and Beverage | Cash or cash equivalent | $20.02 | General |
| Category: Medical Device | ||||||
| 12/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $10.19 | General |
| Category: Obesity | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: PAIN | ||||||
| 11/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $3.25 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Philips North America LLC | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $25.71 | General |
| Category: Medical Device | ||||||
| 11/13/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: HIV | ||||||
| 11/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $5.53 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Bone Health | ||||||
| 10/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: PAIN | ||||||
| 10/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: Cardio-renal | ||||||
| 10/01/2024 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: HIV | ||||||
| 09/18/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $7.01 | General |
| Category: VACCINES | ||||||
| 09/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: PAIN | ||||||
| 08/23/2024 | Philips North America LLC | (5050) Ext Holter (Device) | Food and Beverage | Cash or cash equivalent | $19.06 | General |
| Category: Medical Device | ||||||
| 08/19/2024 | Philips North America LLC | (5050) Ext Holter (Device) | Food and Beverage | Cash or cash equivalent | $3.58 | General |
| Category: Medical Device | ||||||
| 08/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $5.92 | General |
| Category: Obesity | ||||||
| 08/12/2024 | Philips North America LLC | (5050) Ext Holter (Device) | Food and Beverage | Cash or cash equivalent | $2.55 | General |
| Category: Medical Device | ||||||
| 08/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: PAIN | ||||||
| 08/07/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: CNS | ||||||
| 08/06/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 3,266 | 9,916 | $762,529 | $457,428 |
| 2022 | 29 | 3,321 | 10,482 | $759,193 | $452,306 |
| 2021 | 30 | 2,787 | 9,127 | $672,125 | $431,286 |
| 2020 | 29 | 2,735 | 9,387 | $663,790 | $369,818 |
Total Patients
12,109
Total Services
38,912
Medicare Billing
$1.7M
Procedure Codes
121
All Medicare Procedures & Services
121 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 491 | 1,928 | $324,066 | $185,235 | 57.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 50 | 4,560 | $121,661 | $83,786 | 68.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 427 | 427 | $72,933 | $59,725 | 81.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 322 | 686 | $99,613 | $43,503 | 43.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 81 | 98 | $21,100 | $14,803 | 70.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 35 | 44 | $15,180 | $10,237 | 67.4% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 450 | 450 | $13,500 | $9,335 | 69.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 389 | 389 | $9,725 | $8,087 | 83.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 228 | 238 | $10,615 | $7,930 | 74.7% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 225 | 225 | $10,125 | $4,928 | 48.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 22 | 22 | $4,425 | $3,922 | 88.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 13 | 13 | $3,900 | $3,673 | 94.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $7,075 | $3,081 | 43.5% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2023 | 12 | 12 | $3,600 | $3,034 | 84.3% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 19 | 19 | $3,425 | $2,485 | 72.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 27 | 27 | $3,510 | $2,149 | 61.2% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 50 | 173 | $12,855 | $2,137 | 16.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $2,925 | $2,134 | 73.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 94 | 143 | $5,005 | $1,735 | 34.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 42 | 42 | $1,795 | $1,399 | 78.0% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 20 | 37 | $1,909 | $1,064 | 55.7% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 29 | 30 | $1,200 | $810.00 | 67.5% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 14 | 14 | $1,742 | $537.55 | 30.9% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 17 | 17 | $680.00 | $465.80 | 68.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 30 | 32 | $3,180 | $367.14 | 11.5% |
About Dr. Jeffrey Solinas, MD
Dr. Jeffrey Solinas, MD is a Family Medicine healthcare provider based in Watsonville, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1962498006.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Solinas, MD has received a total of $7,970 in payments from pharmaceutical and medical device companies, with $1,342 received in 2024. These payments were reported across 405 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($7,946).
As a Medicare-enrolled provider, Solinas has provided services to 12,109 Medicare beneficiaries, totaling 38,912 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 121 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Watsonville, CA
- Active Since 09/23/2005
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1962498006
Products in Payments
- Ozempic (Drug) $834.60
- EVENITY (Biological) $480.91
- NURTEC ODT (Drug) $403.30
- VRAYLAR (Drug) $383.03
- JARDIANCE (Drug) $289.78
- Epclusa (Drug) $236.67
- UBRELVY (Drug) $201.03
- XARELTO (Drug) $199.87
- Rybelsus (Drug) $193.85
- MOUNJARO (Drug) $185.06
- MAVYRET (Drug) $181.46
- SHINGRIX (Biological) $179.44
- (5050) Ext Holter (Device) $175.84
- Yupelri (Drug) $171.04
- BEXSERO (Biological) $160.11
- Aimovig (Biological) $157.18
- Victoza (Drug) $155.59
- Vivitrol (Drug) $132.35
- Amitiza (Drug) $118.43
- Trintellix (Drug) $117.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Watsonville
Dr. Francis Bayaca, M.d, M.D
Family Medicine — Payments: $10,975
Family Medicine $10,975
Sarah Brant, Md, MD
Family Medicine — Payments: $9,392
Family Medicine $9,392
Mr. Ariel Martinez, Md, MD
Family Medicine — Payments: $4,581
Family Medicine $4,581
Dr. Robert Weber, Md, MD
Family Medicine — Payments: $3,194
Family Medicine $3,194
Dr. Clayton Mcdaniel, Md, MD
Family Medicine — Payments: $3,134
Family Medicine $3,134
Oscar Gantes, Md, MD
Family Medicine — Payments: $1,977
Family Medicine $1,977